|
血管紧张素原基因M235T分子变异与2型糖尿病肾病的关系 |
| |
diol,1993,72(12)∶14H-21H.
2 Jeffers BW, Estacio RO, Raynolds MV,et al.Angiotensin-converting enzyme gene polymorphism in non-insulin dependent diabetes mellitus and its relationship with diabetic nephropathy. Kidney International,1997,52(2)∶473-477.
3 Fogarty DG,Harron JC,Hughes AE, et al.A molecular variant of angiotensinogen is associated with diabetic nephropathy in IDDM. Diabetes, 1996,45(9)∶1204-1208.
4 Fukamizu A, Takahashi S, Seo MS, et al.Structure and expression of the human angiotensiongen gene. J Biolo Chem, 1990,265(13)∶7582.
5 Mauer M, Mogensen CE, Friedman EA. Diabetic nephropathy. In:Schrier RW, Gottschalk CW, eds. Diseases of the kidney. 6th ed. Boston:Little,Brown and Company, 1997.2020-2021.
6 Marre M, Bernadet P, Gallois Y, et al.Relationships between angiotensin I converting enzyme gene polymorphism plasma levels, and diabetic retinal and renal complications. Diabetes,1994,43(3)∶384-388.
7 杨凌，王健军，刘薇，等.糖尿病肾病患者血管紧张素Ⅰ转换酶基因多态性分析.中华医学检验杂志，1997，20(5)∶297-298.
8 Tarnow L, Cambien F, Rossing P,et al.Angiotensinogen gene polymorphisms in IDDM patients with diabetic nephropathy. Diabetes,1996,45(3)∶367-369.
9 Jeunemaitre X, Soubrier F, Kotelevtsev YV, et al.Molecular basis of human hypertension:role of angiotensinogen. Cell,1992,71(10)∶169-180.
10 Anderson PW, Do YS, Hsuch WA. Angiotensin Ⅱ causes mesangial cell hypertrophy. Hypertension,1993,21(1)∶29-35.
11 Campbell DJ, Lawrence AC, Towrie A, et al.Differential regulation of angiotensin peptide levels in plasma and kidney of the rat. Hypertension,1991,18(6)∶763-773.
12 Hata A, Namikawa C, Sasaki M,et al.Angiotensinogen as a risk factor for essential hypertension in Japan. J Clin Invest,1994,93(3)∶1285-1287.
上一页 [1] [2] [3] [4] [5] [6]
上一个医学论文： 食管癌及癌旁组织中基因表达的初步研究
下一个医学论文： 家族性热性惊厥的染色单体型相对风险和传递不平衡分析
|
|
|
您现在的位置： 绿色健康网 >> 医学论文 >> 基础医学论文 >> 正文